GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
63 hedge funds and large institutions have $81.6M invested in Aevi Genomic Medicine, Inc. in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 9 reducing their positions, and 2 closing their positions.
Holders
63
Holders Change
+12
Holders Change %
+23.53%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
28
Reduced
9
Closed
2
Calls
$284K
Puts
–
Net Calls
+$284K
Net Calls Change
-$29K
Top Buyers
| 1 |
BC
1
Broadfin Capital
New York
|
$18.3M |
| 2 |
2
Jennison Associates
New York
|
$10.5M |
| 3 |
3
Adage Capital Partners
Boston,
Massachusetts
|
$5.42M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$4.61M |
| 5 |
BBA
5
Baker Bros. Advisors
New York
|
$4.61M |
